Business
Investors, researchers and high-tech experts gather for Israel’s first International Summit for Accelerating Cannabis Innovation.
Hi, what are you looking for?
Investors, researchers and high-tech experts gather for Israel’s first International Summit for Accelerating Cannabis Innovation.
The generic drugmaker expects the new Israeli facility to generate $100 million in revenue annually.
Teva Pharmaceutical Industries Ltd. will try to win fast European Union approval for its takeover of Allergan’s generics unit by making concessions to regulators,...
Merck KGaA will fund research in immuno-oncology and immunology with up to €1 million each per year for 3 years.
Neuronix’s neuroAD is already commercially available in Europe, Asia and Israel for slowing disease progression in mild to moderate Alzheimer cases.
RedHill Biopharma Ltd., an Israeli biopharmaceutical company today announced a research collaboration with Leipzig-based Fraunhofer Institute for Cell Therapy and Immunology (IZI), a research unit...
In a letter to the Federal Trade Commission (FTC), The American Antitrust Institute (AAI), a non-profit organization, outlined the competitive concerns raised by the proposed merger...
V-Wave's device for treating chronic symptomatic heart failure has been successfully implanted in 30 patients.
Clinical Trial Results Provide Strong Indication That Stem Cell Treatment Inhibits ALS Disease Progression In 87 percent of Patients
The company is changing cartilage and osteoarthritis treatment.